Pharmaceutical drugs: this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | Undetermined |
Veröffentlicht: |
Lyon
1990
|
Schriftenreihe: | Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans
50 |
Schlagworte: | |
Beschreibung: | 415 S. |
ISBN: | 9283212509 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV004365889 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 910612s1990 |||| 10||| undod | ||
020 | |a 9283212509 |9 92-832-1250-9 | ||
035 | |a (OCoLC)231171883 | ||
035 | |a (DE-599)BVBBV004365889 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | |a und | ||
049 | |a DE-12 | ||
245 | 1 | 0 | |a Pharmaceutical drugs |b this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
264 | 1 | |a Lyon |c 1990 | |
300 | |a 415 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans |v 50 | |
650 | 0 | 7 | |a Carcinogenität |0 (DE-588)4206051-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 0 | 1 | |a Carcinogenität |0 (DE-588)4206051-5 |D s |
689 | 0 | |5 DE-604 | |
830 | 0 | |a Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans |v 50 |w (DE-604)BV000878150 |9 50 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-002710829 |
Datensatz im Suchindex
_version_ | 1804118546557435904 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV004365889 |
ctrlnum | (OCoLC)231171883 (DE-599)BVBBV004365889 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01395nam a2200337 cb4500</leader><controlfield tag="001">BV004365889</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">910612s1990 |||| 10||| undod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9283212509</subfield><subfield code="9">92-832-1250-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231171883</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004365889</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical drugs</subfield><subfield code="b">this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Lyon</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">415 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans</subfield><subfield code="v">50</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Carcinogenität</subfield><subfield code="0">(DE-588)4206051-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Carcinogenität</subfield><subfield code="0">(DE-588)4206051-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans</subfield><subfield code="v">50</subfield><subfield code="w">(DE-604)BV000878150</subfield><subfield code="9">50</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002710829</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV004365889 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T16:12:01Z |
institution | BVB |
isbn | 9283212509 |
language | Undetermined |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002710829 |
oclc_num | 231171883 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | 415 S. |
publishDate | 1990 |
publishDateSearch | 1990 |
publishDateSort | 1990 |
record_format | marc |
series | Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans |
series2 | Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans |
spelling | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 Lyon 1990 415 S. txt rdacontent n rdamedia nc rdacarrier Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans 50 Carcinogenität (DE-588)4206051-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Arzneimittel (DE-588)4003115-9 s Carcinogenität (DE-588)4206051-5 s DE-604 Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans 50 (DE-604)BV000878150 50 |
spellingShingle | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 Centre International de Recherche sur le Cancer <Lyon>: IARC monographs on the evaluation of carcinogenic risks to humans Carcinogenität (DE-588)4206051-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
subject_GND | (DE-588)4206051-5 (DE-588)4003115-9 (DE-588)1071861417 |
title | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
title_auth | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
title_exact_search | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
title_full | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
title_fullStr | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
title_full_unstemmed | Pharmaceutical drugs this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
title_short | Pharmaceutical drugs |
title_sort | pharmaceutical drugs this publication represents the views and expert opinions of an iarc working group on the evaluation of carcinogenic risks to humans which met in lyon 17 24 october 1989 |
title_sub | this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17 - 24 October 1989 |
topic | Carcinogenität (DE-588)4206051-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
topic_facet | Carcinogenität Arzneimittel Konferenzschrift |
volume_link | (DE-604)BV000878150 |